Chuanxin Biomedical
Latest round
- Angel
Last raised
- Jan 2022
Total raised
- Undisclosed
Investors
- 4
About Chuanxin Biomedical
Established in 2021 and based in Suzhou, China, Chuanxin Biomedical operates as an RNA drug research and development service provider, dedicated to the commercial development of RNA drugs. The founder, Jianxin Chen, is the co-founder of Acuitas Therapeutics Inc. In May 2021, the company received a license from Acuitas to use its nanolipid particle delivery technology. Through LNP delivery technology, the company has established an mRNA drug development and scale up production system, and also developed novel infectious disease and tumor mRNA vaccines. Chuanxin Biomedical has also developed four core technology platforms, including a nucleic acid technology innovation platform, a delivery technology development platform, an LNP manufacturing platform and, a bioevaluation platform.
Who invested in Chuanxin Biomedical
4 investors across 2 rounds
See all investors in Chuanxin Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chuanxin Biomedical
Who invested in Chuanxin Biomedical?
Chuanxin Biomedical has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chuanxin Biomedical raised?
Chuanxin Biomedical has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Chuanxin Biomedical last raise money?
Chuanxin Biomedical's most recent round on record is a Angel, in Jan 2022.
What does Chuanxin Biomedical do?
Established in 2021 and based in Suzhou, China, Chuanxin Biomedical operates as an RNA drug research and development service provider, dedicated to the commercial development of RNA drugs.
Where is Chuanxin Biomedical headquartered?
Chuanxin Biomedical is headquartered in Suzhou, China.
Which VCs invest in companies like Chuanxin Biomedical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Chuanxin Biomedical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Chuanxin Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.